Plastopil 2025: The mix is more medical, but cash is still tight
Plastopil enters 2026 with a larger medical leg and a broader platform, but still with weak industrial profitability and tight cash flexibility.
March 26, 2026
Plastopil
Producer of flexible packages for food industry.
Sector: Chemical, Rubber & PlasticMarket cap: NIS 101M
All analyses
Analyses on Plastopil (1)
Follow-up dives
Follow-up dives on Plastopil (2)
Follow-up
Plastopil: Why the industrial activity lost its margin in 2025
Plastopil's medical activity did grow in 2025 and did improve the mix, but gross-margin compression came from the industrial side: weaker exports, broad declines across several product families, and a manufacturing cost base that did not fall with revenue.
March 26, 2026
Follow-up
Plastopil: The financing map after Plastnir and Forem, and the room versus covenants
Plastopil ended 2025 with a financing structure that remains under control, but only because consideration was spread across equity, deferred payments, and covenant relief. 2026 has to translate the expansion into EBITDA, cash, and working-capital release if financing pressure i…
March 26, 2026
Same sector
